key: cord-0894461-tyapi9h4
authors: Khubchandani, Jagdish; Price, James H.; Sharma, Sushil; Webb, Fern J.
title: COVID-19 Infection Survivors and the Risk of Depression and Anxiety Symptoms: A Nationwide Study of Adults in the United States
date: 2022-01-12
journal: Eur J Intern Med
DOI: 10.1016/j.ejim.2022.01.021
sha: d5bce0bce0dfd3dc9cb7c10418915d761f4e6b87
doc_id: 894461
cord_uid: tyapi9h4

nan

A multi-component online questionnaire was deployed via Amazon mTurk and community networks throughout the U.S. using emails and social media sites in May 2021 after approval from the Institutional Review Board. After reading an informed consent form, individuals who were 18 years of age or older and resided in the U.S. could participate in the study. The first section of the survey asked participants about history of COVID-19 infection with response options 'yes' vs. 'no' for infection history. To assess psychological distress in the study population, the valid and reliable Patient Health Questionnaire-4 (PHQ-4) tool was used to assess clinical levels of depression (PHQ-2), anxiety (GAD-2), and moderate to severe psychological distress symptoms (i.e., symptoms of both depression and anxiety) [7] . Cronbach alphas for scales were computed from the final sample of respondents in this study, and the internal consistency reliability was found to be acceptable for PHQ-2 (alpha=0.69), GAD-2 (alpha=0.72), and PHQ-4 (alpha=0.81). The final section of the study questionnaire asked participants about their sociodemographic information.

A total of 3,633 participants responded to the questionnaire and were predominantly White (61%), males (61%), married (63%), working full time (79%), urban dwellers (57%), and with a bachelor's degree or higher (65%) [ Table 1 ]. Almost a quarter of the participants reported a history of COVID-19 infection (23%) and more than a third had symptoms of depression (47%), anxiety (40%), or both depression and anxiety (38%). Those who had symptoms of depression were statistically significantly more likely to be Hispanics (58%), White (52%), aged 18-25 years (50%), married (50%) or divorced/separated (46%), living in rural areas (56%), earning $30,001-$60,000 annually (53%), and had a history of COVID-19 infection (64%). Symptoms of anxiety were significantly more likely to be reported by Whites (46%), Hispanics (45%), aged 18-25 years (43%), married (42%), living in rural areas (49%), earning $30,001-$60,000 per year (45%), and those had a history of COVID-19 infection (63%). Similarly, psychological distress (i.e., symptoms of both depression and anxiety) were more likely to be reported by Whites, Hispanics, younger (18-25-year-old), married, earning $30,001-$60,000 per year, living in rural areas, or those with a history of COVID-19 infection (60%) [ Table 1 ].

Logistic regression analyses were conducted to assess the probability of depression and anxiety symptoms in those with a history of COVID-19 infections (those without a history of COVID-19 infection were treated as the reference category) [ Table 2 ]. In unadjusted analyses, COVID-19 infection survivors were significantly more likely to have moderate or severe psychological distress (OR= 3.16; 95%Ci=2.70-3.71) and more specifically, symptoms of either depression (OR=2.31; 95% Ci=1.97-2.72) or anxiety (OR=3.49, 95% Ci=2.97-4.10). In the final regression model, we adjusted for eight sociodemographic characteristics (from table 1) and found that those who had survived a COVID-19 infection were about two and a half times (AOR=2.58) more likely to have moderate to severe psychological distress, almost three times more likely to report anxiety symptoms (AOR=2.93), and almost twice as likely to report symptoms of depression (AOR=1.83), compared to those who did not have a COVID-19 infection.

In this national assessment of U.S. adults, we found that compared to those without a history of COVID-19 infection, those who had been infected with COVID-19 were more likely to report anxiety, depression, or symptoms of both. Anxiety was the most significant difference of mental health sequalae reported among COVID-19 infection survivors. While these findings confirm the evidence from clinical studies, the pathways for development of psychological distress in COVID-19 infection survivors remain a subject of ongoing investigation [3, 4, 6] . Clinicians and scholars have speculated on the etiology of psychological distress in COVID-19 infection survivors and a variety of mechanisms have been proposed, including, but not limited to neurobiological changes due to the pathophysiology of the disease, psychological impact of infection, and socioeconomic factors [6, 8, 9] . For example, COVID-19 infections might have mental health consequences since both the highly contagious coronaviruses SARS (Severe Acute Respiratory Syndrome coronavirus) and MERS (Middle East Respiratory Syndrome) had been found to increase post-illness anxiety and depressed mood [2] . Recent studies also suggest that structural brain abnormalities could be seen in more than a quarter of all COVID-19 patients [3] .

Systemic inflammation and biomarker abnormalities related to infection severity have also been linked with neuropsychiatric problems in COVID-19 infection survivors. Additional factors have also been proposed that could cause psychological distress among COVID-19 infection survivors such as fear of infecting family members, cost of care and not knowing outcome of illness, home confinement and quarantining, economic hardships and job loss due to disease, and other health complications occurring with COVID-19 infections that can deteriorate mental health [6, 9, 10] .

Given the findings from this study and existing evidence, the etiology and causal pathways of psychological distress in COVID-19 infection survivors appear to be complex and multifactorial. For example, many groups in the U.S. who were more likely to have depression and anxiety before the pandemic were also more likely to have COVID-19 infections and higher rates of depression and anxiety during the pandemic. Also, a very large and rigorous recent study proposes a bidirectional relationship between COVID-19 infections and mental illnesses [7] [8] [9] . Based on these reports and findings from our study, it can be assumed that there could be three broader etiological factors for high rates of psychological distress in COVID-19 infection survivors-neurobiological and pathophysiologic changes related to infection, psychosocial stressors associated with getting infected, and pre-existing mental illness and sociodemographic factors making individuals more vulnerable to COVID-19 infections and subsequent postinfection sequelae such as depression and anxiety [8] [9] [10] . If so, our findings have major implications for clinical practice (e.g., comprehensive clinical evaluation and psychiatric consultation for all COVID-19 patients, and appropriate pharmacotherapy or psychotherapy for COVID-19 infection survivors). Further research is warranted in community-based samples to assess longitudinal trends of psychological distress in individuals with and without prior psychological distress to understand the phenotypes of survivors, duration of psychological distress, and other long-term consequences among COVID-19 infection survivors [7] [8] [9] [10] .

The results of this national assessment are subject to potential limitations. First, this was a cross-sectional and observational study with all traditional limitations of a survey design (e.g., self-reported information, socially desirable responses, recall bias, etc.) which could limit the validity of the findings. Second, the exact history and timing of COVID-19 infections was not ascertained and the type of clinical or psychiatric care received (if any) by those who had the infection was not assessed. Third, while this study involved a large national sample of adult Americans, it is limited to predominantly younger individuals with high education and familiarity with online surveys which could limit the external validity of the findings. Despite these limitations, this is one of the largest population-based studies from the U.S. to have a high representation of racial and ethnic minorities and those who had COVID-19 infections. The sample resembles the U.S. adult population in several ways (e.g., majority of the participants were White, employed full-time, and lived in urban or suburban areas). Finally, the assessment of depression and anxiety symptoms within the past 2 weeks was done by a clinical screening measure indicating current depression and anxiety in the study population to compare these mental health measures between COVID-19 infection survivors versus those who did not have an infection history. 

Assessment of the frequency and variety of persistent symptoms among patients with COVID-19: A Systematic Review

Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic

Psychiatric and neuropsychiatric sequelae of COVID-19-A systematic review

Short-term and long-term rates of postacute sequelae of SARS-CoV-2 infection: a systematic review

6-month neurological and psychiatric outcomes in 236379 survivors of COVID-19: a retrospective cohort study using electronic health records

High-dimensional characterization of post-acute sequelae of COVID-19

Post-lockdown depression and anxiety in the USA during the COVID-19 pandemic

COVID-19: Psychiatric Illness

Bidirectional associations between COVID-19 and psychiatric disorder: retrospective cohort studies of 62 354 COVID-19 cases in the USA

Anxiety, depression, insomnia, and trauma-related symptoms following COVID-19 infection at long-term follow-up